Top

Digestive Diseases and Sciences

Published in:

01-08-2011 | Correspondence

Drug-Induced Autoimmune-Like Hepatitis: A Case of Chronic Course After Drug Withdrawal

Authors: Alexandra Heurgué-Berlot, Brigitte Bernard-Chabert, Marie-Danièle Diebold, Gérard Thiéfin

Published in: Digestive Diseases and Sciences | Issue 8/2011

Excerpt

Dear Editor, …

Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56:958–976.PubMedCrossRef

Björnsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:2040–2048.PubMedCrossRef

Heurgué-Berlot A, Bernard-Chabert B, Diebold MD, Thiefin G. Drug-induced autoimmune-like hepatitis: a case of chronic course after drug withdrawal. Dig Dis Sci. 2011; (Epub ahead of print). doi: 10.1007/s10620-011-1786-8

Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology. 2010;52:748–761.PubMedCrossRef

Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 2010;52:730–742.PubMedCrossRef

Agarwal VK, McHutchison JG, Hoofnagle JH. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol. 2010;8:463–470.PubMedCrossRef

Venulet J. Critical reflection on the collection and evaluation of adverse drug reaction data. Int J Clin Pharmacol Ther Toxicol. 1985;23:S48–S53.PubMed

Kelly WN. The quality of published adverse drug event reports. Ann Pharmacother. 2003;37:1774–1778.PubMedCrossRef

Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology. 2006;43:618–631.PubMedCrossRef

Title: Drug-Induced Autoimmune-Like Hepatitis: A Case of Chronic Course After Drug Withdrawal
Authors: Alexandra Heurgué-Berlot
Brigitte Bernard-Chabert
Marie-Danièle Diebold
Gérard Thiéfin
Publication date: 01-08-2011
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 8/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-011-1786-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2011

Acute Liver Failure and Aplastic Anemia in an 11-Year-Old Girl

Erratum to: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B

The Regulation of Thymic Stromal Lymphopoietin in Gut Immune Homeostasis

Prevalence of Advanced Adenomas in Small and Diminutive Colon Polyps Using Direct Measurement of Size

Dangerous Disappearing Act: Commensal Gut Microbiota After Acute Severe Insults

Erratum to: Esophageal Adenocarcinoma Presenting as Pseudo-Achalasia in a Patient with Juvenile Polyposis Syndrome: An Enemy Out of the Blue

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials